Kerna
Kerna Labs
- Website
- kernalabs.ai
- Last Round
- SeedJan 2025
- Rounds
- 1
About
Biotech company developing a foundation model for mRNA therapeutics to unlock the full potential of mRNA as a universal toolkit for genetic medicine.
Summary
Kerna is a Biotech company based in United States. Its most recent funding was a Seed round in Jan 2025. Investors include Gradient Ventures, Humba Ventures and TAU Ventures.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2025
Investors
Similar Companies
Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Clinical-stage programmable cell therapy company developing engineered T-cell therapies for solid...
Clinical-stage biotech developing next-generation CAR T-cell therapies for cancer patients aiming...
Global contract research organization providing comprehensive drug development and laboratory ser...